Randox helping to transform healthcare in Cameroon following partnership with Martin Luther King Jr Memorial Foundation
Randox helping to transform healthcare in Cameroon following partnership with Martin Luther King Jr Memorial Foundation
Randox helping to transform healthcare in Cameroon following partnership with Martin Luther King Jr Memorial Foundation (LUKMEF)
Treating general health conditions and patients with HIV/AIDs in rural Cameroon is being transformed thanks to an initiative and partnership between global diagnostics company Randox and the not-for-profit organization LUKMEF Cameroon.
Until now thousands of people living in the remote village of Awing, in the Santa District, in the North West region of Cameroon, struggled to pay the costs of travel to the North capital city of Bamenda, in order to be tested for complications associated with conditions like HIV/AIDs. Many never made the journey at all, and many died as a result. Now, following the purchase of the state-of-the-art clinical chemical analyser ‘RX Monza’ has been installed in The Awing Health Centre and testing is being offered at minimal cost for the community.The purchase of the Rx Monza was fully financed by the subsidiary office – LUKMEF Switzerland.
The RX Monza is part of the RX Series which has been developed by Randox to meet the growing needs of clinical laboratory testing. This analyser will open exciting opportunities for both routine and specialised testing including coagulation testing worldwide.
LUKMEF, a non-governmental organisation based in the South West of Cameroon, delivered the RX Monza to the hospital in Awing on the 13th September. LUKMEF was founded in 1999 and has completed dozens of projects in peace building, democracy, education and human rights, helping thousands of Cameroonians live healthier and more powerful lives.
Sharon Martin, LUKMEF Board Member and Director of Youth Programmes, said,
LUKMEF aims to empower communities by enabling them to take responsibility for themselves but poverty has been a major obstacle to that when it comes to accessing healthcare. The cost for transportation to Bamenda, coupled with the cost of testing for complications associated with these life-threatening viruses – even at 1 or 2 GBP – was too high for many and the natural consequence was that many never got the help they needed. By providing very low cost testing for people by installing the RX Monza in the Awing Health Centre, we will ensure that people no longer experience unnecessary suffering caused by poverty.
Collaborating with Randox has been fantastic and we are looking forward to expanding this partnership for future initiatives.
Co-founder of LUKMEF, Mr. Tanyi Christian said,
This is a development in healthcare our communities could have only dreamed of until now. There are over three million people living in this region. This piece of equipment will enable the hospital lab to conduct low cost biochemical testing for patients from more than five villages.
Business Development Manager Colin Palmer for Central Europe, EMA and Sub-Saharan Africa said,
It is fantastic for everyone here at Randox to see real life examples of how we are achieving our goal of revolutionising healthcare worldwide. The RX Monza is a semi-automated chemistry analyser that allows the user increased-testing speed in comparison to manual testing, meaning more samples can be run in less time and at a much cheaper cost. This is going to have a significant impact on the local community and nearby villages who couldn’t afford to pay for transport to Bamenda, the region’s capital. The RX Monza delivers accurate results that Awing hospital can depend on and will help save thousands of lives.
Randox is dedicated to creating innovative high quality products aimed at improving and enhancing diagnostics and people’s wellbeing across the globe. Over 100,000 end users are using Randox products and every second of every day 80 Randox tests are used across the world.
For further information please contact our Randox Comms Team on 028 9442 2413 or email randoxpr@randox.com
We Are Randox | Introducing our Randox Health Grand National Graphic Designer, Anne Smith
As a global company with over 1400 employees of 44 different nationalities, we know that the key to success is having a diverse and multi-talented team.
We’re passionate about celebrating the talent and creativity of our Randox employees who make Randox as great as it is today, and who each have their own unique and interesting story to tell.
This week, we had a quick Q&A session with our Lead Graphic Designer, Anne Smith, to hear about her role in Team Randox and what makes her job so exciting.
Spoiler Alert: She’s designed the logo for the world’s greatest race…
Anne, tell us a bit about your background and how you came to be Lead Graphic Designer at Randox.
I studied Art for GCSE and A-Level before choosing to study Graphic Design and Illustration at Ulster University’s Belfast Campus. My course was really interesting and it allowed me to get to grips with using digital design software, including the key Adobe software packages; Photoshop, Illustrator and InDesign. I particularly enjoyed studying the more niche design areas of Typography and Illustration, and learning these new skills instilled in me the ambition to work in a fast-paced, international company with a wide range of different design projects on offer. I wanted to not only utilise my current design skills, but also have the opportunity to learn new ones. So that’s what motivated me to apply for a job at Randox when I graduated!
How did you originally find out about roles in Graphic Design at Randox?
I found out about opportunities in Graphic Design at Randox through the Job Centre NI. Randox has always been a name that people in Northern Ireland know as a key business and employer, but I never really thought about there being Graphic Design jobs in a diagnostics company! I suppose most people think of Graphic Design jobs being in Design or Marketing Agencies, but it’s important to know that many major companies have their own in-house Design Teams. Randox is one such company and has provided me with an incredibly dynamic, exciting job because there’s always something new going on here.
What are the different Graphic Design roles across the company?
We currently have a team of seven Graphic Designers here at Randox and we work across a range of our product divisions. We each have a dedicated product group which we look after – so that could be Randox Quality Control, Randox Biosciences, Randox Health, Corporate Events, or anything in between. As the company grows and the demand for more design material increases, we will want to expand the Graphic Design Team even further.
What does being a designer at Randox involve on a daily basis?
Graphic Design is so varied – one minute I could be designing brochures for a new Randox product, and the next presenting a storyboard concept to our Marketing Managers for a new corporate video. Within each product group we work on producing promotional material such as brochures, pop-up stands, social media graphics, and newsletters. I also look after corporate design such as employee business cards and recruitment adverts.
What has been your proudest achievement while working with Randox?
That would definitely have to be when my design for the Randox Health Grand National logo was officially finalised and released to the public! A lot of hard work and creativity went in to designing the new logo for the world’s greatest race and I’m proud to say that it’s my design.
How did the opportunity come about to design the Randox Health Grand National logo?
We’re very proud of the fact that at Randox we have such fantastic talent in our Marketing teams, and as such we like to keep all elements of our Marketing in-house. When Randox Health and our partners at The Jockey Club decided to create a new logo to accompany the new sponsorship, our Graphic Design Team were given the opportunity to come up with our ideas for the new logo. The final decision was then a two-step process – we presented our logo ideas to our Randox Marketing Managers, and The Jockey Club Team, and we also let all Randox employees vote for their favourite logo. I was delighted when my design was chosen!
What’s the creative process involved in coming up with a new design?
Every piece of design is different but in this instance there were a lot of key messages we wanted to get across with the Randox Health Grand National logo. When we’re asked to produce a new design we’re usually given a brief with the key messages, and in this case it was the speed, agility and excitement of horse racing. So I went away and came up with a few different concepts that I felt portrayed this speed and excitement, and after much consideration chose my final design!
What does it feel like knowing your design will be seen by 600,000,000 people across the world during the Randox Health Grand National?
Really exciting! Our team went to the Grand National 2016 in April, and the site is incredible. The racecourse and the surrounding site is so expansive, and to think that my logo will be displayed across it, and therefore seen by the world, is just amazing.
Between now and April when the Randox Health Grand National takes place, what artwork will you be creating?
There’s a lot of branding that needs to be done – for the racecourse, the Aintree site, the Liverpool area, and additionally lots of adverts, editorials and online branding such as for our website and social media. We won’t be short of work to do!
Do you have any advice for people considering a job in Graphic Design?
There are many challenges that come with working in Graphic Design. Quite often the creation of a new design can be a lengthy process, as you will have to make several changes and amendments to a design before a final concept is chosen. However, it is important to appreciate the huge amount of thought and consideration put in to each and every element of a new design, and to know that all the hard work will be worth it in the end! There is no prouder feeling than seeing your hard work going to print. I never thought that I would be the Designer for the Official Randox Health Grand National logo, but here I am, and I couldn’t be prouder.
If you have any questions for Anne about what it’s like working in the Randox Graphic Design Team, you can contact her via email: anne.smith2@randox.com or for current vacancies, click here .
Make sure to follow Randox Careers on Facebook, Twitter and Instagram to stay up-to-date with the hashtag #WeAreRandox
App that warns children about dangerous stress levels wins Randox Invent 2016 award
A gaming app that helps children learn how to deal with stress and prevent serious mental health problems has scooped one of Northern Ireland’s most prestigious prizes for innovation during the annual INVENT Awards. Entrepreneur Fintan Connolly, a pharmacist, won the Randox-sponsored Life and Health category for his app which is based on providing real-time biofeedback to players – educating young people and helping them consciously control their emotions.
Following the ceremony last night an emotional Fintan said,
“This is a validation of all I’ve done – it is recognition that you’re on the right path, that what you’re doing is meaningful. I’ve always been fascinated by stress particularly in young children, and I wanted to upskill kids to help them deal with everyday situations. Young people face greater mental health problems today than ever before – the figures are startling and frightening. If they don’t understand the concept of self-regulation – they can’t understand the sense of empowerment. However by showing them in a visual way what is happening inside them, they get it. You use technology to help them because that is their domain.”
As well as sharing the £33,000 prize fund, the Take Ten team now travels to California as part of the NI Tech Mission. TakeTen are due to launch an advanced version of the app next month, which is designed to specifically support children diagnosed with cancer. Early in the New Year, they’ll also begin trials of the app in schools in California.
Randox Chief Scientist John Lamont who was part of the judging panel said,
“We were very proud to sponsor the Life and Health award at Invent 2016. This competition, run by Catalyst Inc, plays a crucial role in supporting the many inspiring innovators across Northern Ireland. We recognise that desire as it was of course the very reason Dr Peter FitzGerald established Randox and why we established our own student and graduate programmes, which had a record intake this year. The judges were blown away by the quality of the ideas we were presented with during Invent 2016, and every one that made it through to the finals of this prestigious competition deserved their place. Fintan’s passion to improve the health of young people was clear from the start and his app has great potential. We look forward to following his journey and wish him the very best in the future.”
For further information contact Nicola McHugh nicola.mchugh@randox.com
Randox Health to sponsor the two feature contests at The Showcase
Randox is pleased to announce that Randox Health will sponsor two £50,000 handicap chases at The Showcase on Saturday, October 22 – the Randox Health Handicap Steeple Chase (3.30pm) over two miles and the Randox Handicap Steeple Chase (1.50pm) over three miles and a furlong.
Earlier this year, Randox Health signed a five-year agreement to become title sponsors of the Randox Health Grand National at Aintree from 2017 and was also unveiled as the official healthcare partner of The Jockey Club, joining an esteemed and growing list of Group Partners. By embarking on this Group-wide partnership the Jockey Club is striving to raise Randox Health’s message of preventive health and wellbeing amongst its members, and to the wider racing audience of all Jockey Club Racecourses.
The Randox Health Handicap Steeple Chase and the Randox Handicap Steeple Chase are the richest races over the two days of The Showcase, which gets Cheltenham’s new season underway on Friday and Saturday, October 21 and 22.
Popular chaser Balthazar King captured the Randox Handicap Steeple Chase three years on the bounce (2011, 2012, 2013) and was runner-up to Pineau De Re in the 2014 Grand National.
The Randox Health Handicap Steeple Chase, run at two and a half miles up to and including 2014, has provided some valuable pointers to the BetVictor Gold Cup at The Open in November. Johns Spirit captured both races in 2013, as did Shooting Light (2001) and The Outback Way (1999).
Dr. Peter FitzGerald, Founder and Managing Director of Randox Health, is looking forward to The Showcase which marks the beginning of the roll out of Randox Health branding across Jockey Club courses;
“We are thrilled to be able to bring the name of Randox Health to the participants and viewers of the Randox Handicap Steeple Chase and the Randox Health Handicap Steeple Chase. The races mark the beginning of our partnership with the Jockey Club, whose courses are the perfect platform to highlight the benefits of our Randox Health Preventive Health Programmes to the public, and also to bring the other diagnostic capabilities of our healthcare company, including Equine Health and Food Testing, amongst others, to the attention of equestrian enthusiasts. Our health is our most valuable commodity and so we want to keep the horse racing fraternity healthy so they are able to enjoy such fantastic events as The Showcase.”
Carey Buckler, Regional Head of Partnerships, South West Region, Jockey Club Racecourses, said: “I am delighted that Randox Health are to sponsor at Cheltenham during The Showcase.
“Their involvement with The Jockey Club is really exciting and it is great that we are able to work with them across the group ahead of next year’s Randox Health Grand National.”
For further information please contact our Randox Comms Team on 028 9445 1016 or email amy.mcilwaine@randox.com
Randox and Chan Zuckerberg Initiative share common goal
You may have read in the news this week that the Chan Zuckerberg Initiative co-founded by Mark Zuckerberg has pledged to invest $3 billion over the next decade to help further and advance medical research. Investments will go towards a research facility, named the Biohub, which will focus on developing new tools to research, understand and treat diseases, and of particular interest to us here at Randox, on creating a chip to diagnose disease.
Here at Randox we fully support this drive to further research that is devoted to revolutionising healthcare. We commit up to 16% of turnover to research and development each year and currently over 20% of the world’s major laboratories are using Randox products.
In particular, we invested £220 million into the development of our Biochip Array Technology (BAT). The Randox biochip has revolutionised the diagnostics industry by facilitating the detection of a wide range of markers of disease from a single undivided sample. This not only enhances patient diagnosis but reduces the amount of time spent on individual tests and associated laboratory costs.
Our expertise, highly specialised scientists and world-class ISO accredited manufacturing facilities enables early, accurate, informed clinical decisions in the areas of veterinary testing, molecular research and diagnostics, drug development, food safety and forensic and clinical toxicology.
Our Randox Health clinics use our Biochip to allow people to avail of the complete portfolio of Randox routine and novel tests to empower their health decisions. This new and exciting service provides personalised and preventive health profiling for each individual.
Speaking about the biochip Dr. Peter FitzGerald, Founder and Managing Director of Randox said,
“Many years of development and the expertise of our highly qualified scientists have gone into the creation of Randox Biochip Array Technology. This scientific development will facilitate the simultaneous quantitative or qualitative detection of a wide range of analytes from a single undivided sample. This approach both proteomic and genomic enables an enhanced patient diagnosis, optimum efficiency and consolidation of cost. Our arrays are suitable for use in a wide range of settings including clinical and research laboratories, biopharmaceutical organisations, forensic and clinical toxicology, hospital laboratories, food testing and veterinary laboratories.”
We are delighted that Chan Zuckerberg’s interest in this area brings to the forefront the importance of improving healthcare through innovative diagnostics. It is clear that Randox and the Chan Zuckerberg Initiative share a common goal to revolutionise healthcare worldwide and we believe that the Randox Biochip can play an important role in realising this vision.
For further information please contact our Randox Comms Team on 028 9445 1016 or email amy.mcilwaine@randox.com
Grand National sponsor Randox hosts Polo event in Bushmills, Northern Ireland
New Grand National sponsor, Randox hosted a unique event in Bushmills this weekend – an International Polo tournament with teams taking part from Northern Ireland, the Republic of Ireland, Scotland, and South Africa.
Guests from around the world who made the journey to Northern Ireland for the Polo event were given a warm welcome – they were treated to an intimate performance from world renowned concert pianist Barry Douglas on the evening of Friday 16th September, in the recently acquired Dundarave Estate.
The Randox NI Polo was the first of its kind and over 500 guests made their way to the North Coast town to attend the inaugural event. The day kicked off with the Police Service Northern Ireland pipe band who entertained the crowds before the tournament began. Guests included Pamela Ballantine and the Lord-Lieutenant of County Antrim, Mrs. Joan Christie OBE who delivered the match ball of the opening game.
It was a victory for Scotland during the first nail-biting game of the tournament, as they went head to head with the team from Northern Ireland. But it was South Africa who emerged the winners of the 2016 tournament, after beating the team from the Republic of Ireland and scoring more goals than any other team. The weekend’s events ended with a Gala Ball and dinner, followed by a breath-taking firework display which was also enjoyed by members of the Bushmills community.
Randox Founder and Managing Director, Dr. Peter FitzGerald, a keen horseman and horse sports enthusiast, said he is looking forward to the highly anticipated Polo event;
“We’ve been engaged on the Point-to-Point scene in Northern Ireland for many years, close to our Randox headquarters in County Antrim, but up until now have never had the opportunity to also host a Polo tournament in Northern Ireland. We’re delighted to be able to now hold the event in the beautiful scenery of the North Coast and to bring the Randox Health message to our Polo guests. By taking care of your wellbeing you can ensure that you enjoy days out in Northern Ireland – such as the Randox Polo event – to the fullest.”
Earlier this year, it was announced that Randox Health will sponsor the Grand National, in a five year deal which starts in 2017.
At the time of the sponsorship announcement earlier this year, FitzGerald commented;
“We see this partnership as a natural fit, as both organisations invest heavily in the future and we aim to use our partnership to promote a positive lifestyle and to bring enjoyment to millions of people. We care about people’s health and this is the people’s race.”
As the company expands and develops – more than 370 million people across 145 countries now receive medical diagnosis via Randox products – it seems fitting that Randox would move from the local horse sports scene to the world’s greatest race.
But the global healthcare company is remaining true to its roots, continuing to host the Point-to-Point events that have been synonymous with the company for so long. And by bringing the Polo event to Bushmills, and opening its doors to the public, Randox is saying ‘we haven’t forgotten where we come from.’
Randox unveils Future of Diagnostics Technology at Annual Global Distributorsā Conference
The future of diagnostic healthcare has been unveiled at the Randox Science Park in Antrim, as the company’s annual global distributors’ conference gets underway. Delegates from more than 90 countries are taking part in the world-leading healthcare firm’s three-day event at the Hilton Hotel in Templepatrick.
As well as discussions about developments in reagents and quality control products, participants enjoyed demonstrations of Randox’s patented Biochip Array Technology and its extensive range of analysers from the RX Series.
Melansha Fernando from Alpha and Omega Diagnostics in Sri Lanka said,
“Randox has released so many new products recently that laboratories in my country are increasingly interested in what it can offer. As a result I felt it important to come here to learn more about the new technologies. The truly global nature of the company has been impressed upon me after meeting colleagues from so many different countries – I’m delighted to have been able to take part.”
Speaking at the conference, Dr. Peter Fitzgerald said,
“All exporters are aware of the considerable challenges we must overcome in order to do business in the global market but year on year our teams across the world have helped to drive our success. One of the biggest challenges Randox faces is the one we put to ourselves, to deliver truly transformative technologies and improve health worldwide. We recently celebrated our £1 billionth sale and we now look to build on that achievement and accelerate our rate of growth. All of our profits go straight to either R&D, or the development of our infrastructure, so strong growth is key to our goal of revolutionising diagnostics and saving lives across the world.”
Susan Hammond, Global Reagents Sales Manager said,
“It is a pleasure to see the diversity of our distributors gathered together in one room, and recognize how far we have come as an international company. We dedicated Thursday to focusing on building relationships with our worldwide distributors to ensure that they attain the best product knowledge available. Over 100,000 end users employ Randox products and every second of every day 80 Randox tests are used across the world, and it is vital our distributors are kept up to date with every new development.”
For more information on the Distributors’ Conference contact Amy in our PR Team by calling 028 9445 1016 or email amy.mcilwaine@randox.com
Randox hosts Polo Weekend 2016 in Scotland
Piano, polo and cardiac risk profiles were part of the mix enjoyed by more than a hundred guests from around the world at the annual Randox Laboratories’ weekend in Scotland.
World-renowned concert pianist Barry Douglas launched the event at Gleneagles Hotel with an intimate recital of his new music, as well as performing O’Carolan’s “Farewell to Music” and Tchaikovsky’s “Autumn Song.” The evening concluded with dinner and a talk from Manufacturing Manager David Martin who presented Randox’s innovative plans for the future which included our new state of the art Science Park.
A range of impressive seminars were held on Saturday morning, many of which were live-streamed for the first time on our social media channels to international followers. Guests were shown ground-breaking studies completed using Randox products, with the potential to truly transform the way healthcare is delivered. Highlights included a talk by Professor Ray Sherwood from Kings College London who studied “Cytokines for Diagnosis of POEMS syndrome and Castleman Disease” and research by Dr Ibrahim Mansoor from the International Medical Centre in Jeddah on “Extended Lipid Profile, Roles of sLDL”.
The polo match ball was hand delivered to Dr Peter FitzGerald by the Red Devils Parachute Regiment who impressed the crowds by jumping from thousands of feet up in the air to land squarely on the field at Errol Park. Some of the world’s best players took part including Sébastien Pailloncy (3-goals) who wore the England jersey. After three games, England were crowned the 2016 winners, South Africa followed closely behind as the runner up while Scotland came in at third place.
As well as the action on the polo field, guests enjoyed browsing a selection of stalls assembled by the Prince’s Trust (Randox official corporate charity) which included businesses such as “Maddy Burrows Illustrations,” “My Fantasy Bouquet” and “The Family Tree”.
The weekend’s events concluded that evening with the Highland Ball and dinner, followed by a breath-taking firework display – which was also enjoyed by members of the Errol community!
Plans are already underway for our next Polo Weekend – held this weekend for the first time at Dundarave House in Bushmills, Northern Ireland.
Randox welcomes record number of people to its student placement and graduate programme
71 people including scientists, engineers and IT specialists, from across the UK and Europe are taking the first steps in their Randox careers this week, as the company celebrates a record intake to its student placements and graduate programmes.
Now in its 26th year of providing student placements and 6th year for graduate programmes, Randox is recognised internationally for providing world-class opportunities for students and graduates – one of the core reasons that the global diagnostics company was established in 1982. Thirty years on, its founder Dr Peter FitzGerald remains as committed as ever to championing new talent and driving innovation.
Nadine McKerrow, who graduated this summer with a 2.1 in Biomedical Science from Ulster University, said,
“It’s always been my ambition to work for Randox because of the value it puts into R&D which is my speciality. Not only does it invest 16% of turnover into it – which is something very few companies do, but it’s also building the Randox Science Park which will house pioneering R&D labs. The research we do is going to make an incredible difference to saving lives and improving health, and I’m very proud to be part of the team.”
One of a number of people who have moved to Northern Ireland to take up a placement post is Ross Moir, a Chemistry student from the University of Edinburgh. He said,
“When I go into the lab, I am working beside people who came up with the test that detects Alzheimer’s – it’s incredibly inspirational. I’m not standing on the side-lines either – I’m getting right into the nitty-gritty of the work here. On-the-job experience with a company that is right now developing more new tests than any other diagnostics company in the world is an amazing opportunity.”
Randox founder Dr Peter FitzGerald said,
“I am pleased to welcome these ambitious and bright young people from across the UK and Europe to join the Randox team; they are key to continuing our success. It is no exaggeration to say that during the course of their careers many of them, through their innovative work in diagnostics within the labs at Randox, will save lives. The importance of supporting STEM students has never been so important, a fact recognised by business and political leaders across the world, and here at Randox we are delighted to be playing a significant part in that.”
University students across a range of disciplines take part in a 50-week placement with Randox. They gain invaluable experience in fields ranging from Business and Marketing to Biological and Life Sciences, Graphic Design to Mathematics and Physics, and Engineering to Computer Technology. At the end of their placements, subject to attaining a 2.1 degree or above, students are offered a full-time position in their chosen field.
Graduates enter a two-year programme, which is divided into a series of six-month placements, designed to provide a valuable insight into a variety of roles and departments. Many of the successful graduates who join Randox in full-time positions after this have progressed to attain senior positions within the Company.
Randox Reagents: Solving the Problem of Heart Attack Misdiagnosis
A report has today revealed that almost a third of patients in England and Wales are being given a misdiagnosis following a heart attack, following a study of 243 NHS hospitals, conducted by researchers at Leeds University.
Timely evaluation of patients with chest pain and subsequently suspected heart attack is a major challenge for hospitals around the world, with chest pain typically representing around 5% of all visits to the Emergency Department (ED) and 25% of ED admissions. One of the biggest challenges facing emergency doctors now is how to prioritise people presenting with chest pain – to primarily deal with those suffering from a heart attack, and to be able to move those who are not, to a different ward, to alleviate the pressures of the overrun A&E departments.
Responding to the escalating misdiagnosis crisis in emergency hospitals across the globe, scientists at Randox Laboratories in the UK have developed a test which could help clinicians rule out heart attacks in patients immediately upon arrival at hospital; allowing clinicians to accurately prioritise those who have truly suffered heart attacks.
This Randox test, for Heart-type fatty acid-binding protein (H-FABP), is a highly sensitive biomarker for use in the earlier diagnosis of patients with suspected Acute Myocardial Infarction (AMI), enabling faster “rule-in” and “rule-out”. H-FABP is detectable as early as 30 minutes after chest pain onset, significantly earlier than traditionally used biomarkers such as Troponin or CK-MB , which typically require 6-12 hours to reach detectable concentrations.
Put simply, given that H-FABP is released earlier than traditional biomarkers used in diagnosing a heart attack, an earlier diagnosis is achievable.
A succession of recent international clinical trials have demonstrated that by combining H-FABP, via this new laboratory assay, with the existing tests already used in hospitals for for Troponin I or Troponin T, the sensitivity and negative predictive value for ruling out AMIs is significantly improved.
Growing evidence indicates that even when one of the newer generation of “highly sensitive” Troponin assays is used, utilising the combination of Troponin and H-FABP is superior to Troponin alone.
The value of H-FABP is not just in positive diagnosis – but doctors are beginning to see it as a means of ‘ruling out heart attack’ when a patient presents at A&E with chest pain.
Please do get in touch if you would like to find out more about our H-FABP test, and how this can go a long way in solving the heart attack misdiagnosis crisis, by emailing reagents@randox.com
